Por: The New York Times Health June 16, 2023
The NewsVaccine makers should target the XBB variant of the coronavirus in a shot to be available in the fall, moving away from the existing formula that protected against the Omicron variant and an early form of the virus, an advisory panel to the Food and Drug Administration agreed on Thursday.The 21-member panel unanimously recommended that manufacturers should aim at the most dominant variant of the coronavirus this summer. If the F.D.A.... + full article
RTTNews USA Health March 15, 2023
The U.S. Food and Drug Administration has authorized bivalent Pfizer-BioNTech covid-19 vaccine as booster dose for certain children 6 months through 4 years of age.In a statement, the regulator said it has amended the emergency use authorization or EUA of the Pfizer-BioNTech... + más
FDA Authorizes Bivalent Pfizer Covid Vaccine As Booster Dose For Select Children Under 5 | RTTNews
Amid pathetic uptake, FDA green lights confusing COVID vaccine update for kids | Ars Technica
10 WBNS USA Health January 10, 2023
It’s been three years since the coronavirus emerged, and now a new variant is spreading. The most prevalent mutant in the U.S. as of early January is XBB.1.5, which makes up 41% of U.S. cases. Experts told this variant attaches more tightly than its competitors to a receptor... + más
Quick and stealthy 'Scrabble variants' are poised to drive a winter Covid-19 surge | CNN
Biden Covid officials scramble to plan for Omicron subvariant threat | Politico
Portland Press Herald USA Health January 04, 2023
A new variant of COVID-19 is surging in Maine and throughout the Northeast, but the state’s top health official does not expect cases and hospitalizations to soar like they did when the first omicron variant emerged last winter. Dr. Nirav Shah, director of the Maine Center for... + más
What we know about the new COVID-19 variant XBB | The Boston Globe
Covid cases, hospitalizations spike as new variant gains foothold | Politico
NBC 6 South Florida USA World January 04, 2023
NBCUniversal Media, LLC The Covid omicron XBB.1.5 variant has nearly doubled in prevalence over the past week and now represents about 41% of new cases in the U.S., according to CDC data. data-ellipsis=false> , marking a fusion between two recent strains that is even more... + más
Highly Immune Evasive Omicron XBB.1.5 Variant Is Quickly Becoming Dominant in U.S. as It Doubles Weekly | NBC 6 South Florida
What to Know About the New XBB.1.5 Variant | Time
CNBC USA Health December 30, 2022
Pictured here on Dec. 28, 2022, is gymnasium-turned-fever clinic in Fuzhou, Fujian province.Wang Dongming China News Service Getty ImagesBEIJING — It's unlikely that a dangerous new Covid-19 variant is spreading in China, said Dr. Chris Murray, Seattle-based director of a... + más
Reimagining Alzheimer’s (Part 6): The Many Effects Of The APOE4 Variant | Forbes
Forbes USA Tech December 05, 2022
A recent paper published in Nature reveals a new mechanism by which the genetic risk factor APOE4 ... [+] may cause Alzheimer's symptoms.American Society of Human Genetics, Allen School of Health Sciences This article is the sixth installment in my series on Alzheimer’s... + más
A Promising Trial Targets a Genetic Risk for Alzheimer’s | The New York Times
Chris Hemsworth discovers he may be at risk for Alzheimer’s disease in new series, ‘Limitless’ | ABC News
About iurex | Privacy Policy | Disclaimer |